Surmodics to Webcast Third Quarter 2016 Earnings Conference Call on July 28
July 20 2016 - 8:05AM
Business Wire
Webcast is Live at 7:30 a.m. (CT)
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that it will host a live webcast of its
third quarter fiscal 2016 conference call on Thursday, July 28, at
7:30 a.m. CT (8:30 a.m. ET). The Company will issue an
earnings news release earlier that morning.
Gary Maharaj, president and chief executive officer, and Andy
LaFrence, vice president of finance and chief financial officer,
will recap the third quarter 2016 financial results and
accomplishments. To access the webcast, go to the investor
relations portion of the Company’s website at www.surmodics.com the
day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 10:30 a.m.
CT on Thursday, July 28, until 10:30 a.m. CT on
Thursday, August 4, and can be accessed by dialing
888-203-1112 and entering conference call ID passcode 8648070. In
addition, the conference call audio and transcript will be archived
on the Company’s website following the call.
About Surmodics, Inc.
Surmodics is the global leader in surface modification
technologies for intravascular medical devices and a leading
provider of chemical components for in vitro diagnostic (IVD) tests
and microarrays. Following two recent acquisitions of Creagh
Medical and NorMedix, the Company is executing a key growth
strategy for its medical device business by expanding to offer
total intravascular product solutions to its medical device
customers. The combination of proprietary surface technologies,
along with enhanced device design, development and manufacturing
capabilities, enables Surmodics to significantly increase the value
it offers with highly differentiated intravascular solutions
designed and engineered to meet the most demanding requirements.
With this focus on offering total product solutions, Surmodics’
mission remains to improve the detection and treatment of disease
by using its technology to provide solutions to difficult medical
device and diagnostic challenges. Surmodics is headquartered in
Eden Prairie, Minnesota. For more information about the company,
visit www.surmodics.com. The content of Surmodics’ website is not
part of this press release or part of any filings that the company
makes with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160720005313/en/
Surmodics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024